Title : Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1.

Pub. Date : 2020 Jun 9

PMID : 32444490






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1. Metformin solute carrier family 47 member 1 Homo sapiens
2 Mechanistically, the mutated KRAS oncoprotein hypermethylates and silences the expression of multidrug and toxic compound extrusion 1 (MATE1), a specific pump that expels metformin from the tumor cells by up-regulating DNA methyltransferase 1 (DNMT1). Metformin solute carrier family 47 member 1 Homo sapiens
3 Our findings provide evidence that KRAS-mutation mCRC patients benefit from metformin treatment and targeting MATE1 may provide a strategy to improve the anticancer response of metformin. Metformin solute carrier family 47 member 1 Homo sapiens